2008 Clinical Practice Guidelines - Canadian Diabetes Association

2008 CLINICAL PRACTICE GUIDELINES
S178
tion in patients with type 1 diabetes: a longitudinal study.
Diabetes Care. 2003;26:1181-1185.
88. Kitzmiller JL, Gavin LA, Gin GD, et al. Preconception care of
diabetes. Glycemic control prevents congenital anomalies.
JAMA. 1991;265:731-736.
89. McElvy SS, Miodovnik M, Rosenn B, et al. A focused preconceptional
and early pregnancy program in women with type 1
diabetes reduces perinatal mortality and malformation rates to
general population levels. J Matern Fetal Med. 2000;9:14-20.
90. Jovanovic L, Knopp RH, Kim H, et al. Elevated pregnancy
losses at high and low extremes of maternal glucose in early
normal and diabetic pregnancy: evidence for a protective
adaptation in diabetes. Diabetes Care. 2005;28:1113-1117.
91. Suhonen L, Hiilesmaa V, Teramo K. Glycaemic control during
early pregnancy and fetal malformations in women with type I
diabetes mellitus. Diabetologia. 2000;43:79-82.
92. Guerin A, Nisenbaum R, Ray JG. Use of maternal GHb concentration
to estimate the risk of congenital anomalies in the
offspring of women with pre-pregnancy diabetes. Diabetes
Care. 2007;30:1920-1925.
93. Hiilesmaa V, Suhonen L,Teramo K. Glycaemic control is associated
with pre-eclampsia but not with pregnancy-induced
hypertension in women with type I diabetes mellitus.
Diabetologia. 2000;43:1534-1539.
94. Hsu CD, Tan HY, Hong SF, et al. Strategies for reducing the
frequency of preeclampsia in pregnancies with insulin-dependent
diabetes mellitus. Am J Perinatol. 1996;13:265-268.
95. Edison RJ, Muenke M. Central nervous system and limb
anomalies in case reports of first-trimester statin exposure.
N Engl J Med. 2004;350:1579-1582.
96. The Diabetes Control and Complications Trial Research
Group. Early worsening of diabetic retinopathy in the Diabetes
Control and Complications Trial. Arch Ophthalmol.
1998;116:874-886.
97. Rizzo T, Metzger BE, Burns WJ, et al. Correlations between
antepartum maternal metabolism and child intelligence. N Engl
J Med. 1991;325:911-916.
98. Metzger BE, Coustan DR. Summary and recommendations of
the Fourth International Workshop – Conference on
Gestational Diabetes Mellitus. Diabetes Care. 1998;21(suppl 2):
B161-B167.
99. Dyck R, Klomp H, Tan LK, et al. A comparison of rates, risk
factors, and outcomes of gestational diabetes between aboriginal
and non-aboriginal women in the Saskatoon Health
District. Diabetes Care. 2002;25:487-493.
100. Godwin M, Muirhead M, Huynh J, et al. Prevalence of gestational
diabetes mellitus among Swampy Cree women in Moose
Factory, James Bay. CMAJ. 1999;160:1299-1302.
101. Harris SB, Caulfield LE, Sugamori ME, et al.The epidemiology
of diabetes in pregnant Native Canadians. A risk profile.
Diabetes Care. 1997;20:1422-1425.
102. Crowther CA, Hiller JE, Moss JR, et al; Australian
Carbohydrate Intolerance Study in Pregnant Women
(ACHOIS) Trial Group. Effect of treatment of gestational dia-
betes mellitus on pregnancy outcomes. N Engl J Med. 2005;
352:2477-2486.
103. HAPO Study Cooperative Research Group; Metzger BE,
Lowe LP, Dyer AR, et al. Hyperglycemia and adverse pregnancy
outcomes. N Engl J Med. 2008;358:1991-2002.
104. Cutchie WA, Cheung NW, Simmons D. Comparison of international
and New Zealand guidelines for the care of pregnant
women with diabetes. Diabet Med. 2006;23:460-468.
105. Lanni S, Barrett D.The predictive value of the 1-h 50-g glucose
screen for diagnosing gestational diabetes mellitus in a highrisk
population. J Matern Fetal Neonatal Med. 2004;15:375-379.
106. Cheng YW, Esakoff TF, Block-Kurbisch I, et al. Screening or
diagnostic: markedly elevated glucose loading test and perinatal
outcomes. J Matern Fetal Neonatal Med. 2006;19:729-734.
107. Agarwal MM, Dhatt GS, Punnose J, et al. Gestational diabetes:
a reappraisal of HBA1c as a screening test. Acta Obstet Gynecol
Scand. 2005;84:1159-1163.
108. Rey E, Hudon L, Michon N, et al. Fasting plasma glucose versus
glucose challenge test: screening for gestational diabetes
and cost effectiveness. Clin Biochem. 2004;37:780-784.
109. Esakoff TF, Cheng YW, Caughey AB. Screening for gestational
diabetes: different cut-offs for different ethnicities? Am J Obstet
Gynecol. 2005;193:1040-1044.
110. Agarwal MM, Dhatt GS, Punnose J, et al. Gestational diabetes:
dilemma caused by multiple international diagnostic criteria.
Diabet Med. 2005;22:1731-1736.
111. Chico A, Lopez-Rodo V, Rodriguez-Vaca D, et al. Features and
outcome of pregnancies complicated by impaired glucose tolerance
and gestational diabetes diagnosed using different criteria
in a Spanish population. Diabetes Res Clin Pract. 2005;68:
141-146.
112. McLaughlin GB, Cheng YW, Caughey AB. Women with one
elevated 3-hour glucose tolerance test value: are they at risk
for adverse perinatal outcomes? Am J Obstet Gynecol. 2006;194:
e16-e19.
113. Cosson E, Benchimol M, Carbillon L, et al. Universal rather
than selective screening for gestational diabetes mellitus may
improve fetal outcomes. Diabetes Metab. 2006;32:140-146.
114. Pöyhönen-Alho MK,Teramo KA, Kaaja RJ, et al. 50gram oral
glucose challenge test combined with risk factor-based
screening for gestational diabetes. Eur J Obstet Gynecol Reprod
Biol. 2005;121:34-37.
115. Griffin ME, Coffey M, Johnson H, et al. Universal vs. risk factor-based
screening for gestational diabetes mellitus: detection
rates, gestation at diagnosis and outcome. Diabet Med. 2000;17:
26-32.
116. Langer O, Yogev Y, Most O, et al. Gestational diabetes: the
consequences of not treating. Am J Obstet Gynecol. 2005;192:
989-997.
117. Thompson DM, Dansereau J, Creed M, et al. Tight glucose
control results in normal perinatal outcomes in 150 patients
with gestational diabetes. Obstet Gynecol. 1994;83:362-366.
118. Salim R, Hasanein J, Nachum Z, et al. Anthropometric
parameters in infants of gestational diabetic women with